Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1901423	注射用地西他滨	decitabine	Lyophilized	Chemical Drugs	Supplementary Application	2019-12-11	Janssen Pharmaceutica N.V.	Johnson & Johnson Innovative Medicine	In Review	2019-12-10	view
JYHB1401046	硝酸益康唑	Econazole Nitrate	Active ingredient	Chemical Drugs	Supplementary Application	2014-07-30	Janssen Pharmaceutica N.V.	Johnson & Johnson Innovative Medicine	Certificate Issued	2016-09-30	view
JYHB1200380	利培酮	risperidone	Active ingredient	Chemical Drugs	Supplementary Application	2012-05-14	Janssen Pharmaceutica N.V.	Johnson & Johnson Innovative Medicine	Certificate Issued	2013-01-05	view
JYHB1000022	氢溴酸加兰他敏	GALANTAMINE HYDROBROMIDE	Active ingredient	Chemical Drugs	Supplementary Application	2010-01-22	Janssen Pharmaceutica N.V.	Johnson & Johnson Innovative Medicine	Certificate Issued	2012-12-13	view
JXHL0900194	普卡必利琥珀酸盐片	prucalopride succinate	Tablet	Chemical Drugs	Import Drug Application	2009-06-25	Janssen Pharmaceutica N.V.	Johnson & Johnson Innovative Medicine	Certificate Issued	2010-05-31	view
JYHB0700378	注射用BAL5788	ceftobiprole medocaril sodium	Lyophilized	Chemical Drugs	Supplementary Application	2007-04-05	Janssen Pharmaceutica N.V.	Johnson & Johnson Innovative Medicine	Certificate Issued	2007-08-02	view
JXHL0500184	注射用BAL5788	ceftobiprole medocaril sodium	Lyophilized	Chemical Drugs(1.1)	Import Drug Application	2005-09-21	JANSSEN PHARMACEUTICA N.V.	Johnson & Johnson Innovative Medicine	Certificate Completed-Pending Issued	2006-08-04	view